Johnson & Johnson (NYSE:JNJ) said today it launched its Cerenovus brand, which combined its Pulsar Vascular and Neuravi acquisitions and its remaining Codman Neuro neurological portfolio. Cerenovus was launched at the European Society of Minimally Invasive Neurological Therapy’s 9th annual meeting, J&J said. Johnson & Johnson said that the Cerenovus product portfolio aims to help improve stroke care, with the number […]
Neuravi Limited
Johnson & Johnson rolls Pulsar Vascular, Neuravi into new Cerenovus neurovascular biz
Updated to clarify that J&J’s existing Codman Neuro neurovascular portfolio will also be included in the new Cerenovus business. Johnson & Johnson (NYSE:JNJ) said yesterday that it’s medical device division is rolling the Pulsar Vascular and Neuravi acquisitions, as well as its existing Codman Neuro neurological portfolio, into a new neurovascular business dubbed Cerenovus. The […]
Codman Neuro acquires Neuravi
Johnson & Johnson (NYSE:JNJ) business unit Codman Neuro said today it acquired Neuravi and its portfolio of neurovascular therapy technology for an undisclosed amount. Neuravi produces the EmboTrap and EmboTrap II revascularization platforms designed capture clots and allow blood flow to resume immediately after the clot has been secured in patients who have experienced a stroke. J&J’s Codman Neuro […]
Neuravi raises $16.7m
Neuravi said today it raised $16.7 million (EU €15 million) in a new round of debt financing, with funds slated to support U.S. commercialization and portfolio expansion. Money in the round came from healthcare alternative financing provider IPF Partners, the Galway, Ireland-based company said. Funds raised in the round will be invested into the U.S. commercialization […]
Neuravi wins CE Mark for EmboTrap II stent retriever
Neuravi said today it won CE Mark approval in the European Union for its EmboTrap II stent retriever and revascularization device. The device is a next-gen version of the company’s EmboTrap, and is designed to treat a broader range of clots with sizes that are deliverable through a 0.021″ microcatheter. “The EmboTrap platform has been a […]
Neuravi launches clinical trial of Embotrap stent retriever
Neuravi said today it enrolled the 1st patient in a clinical trial of its novel EmboTrap revascularization stent retriever device for treating acute ischemic stroke. Data from the study will be submitted as part of Neuravi’s FDA premarket approval application, the Ireland-based company said. “Working to improve clinical outcomes in stroke is central to Neuravi’s mission, […]
Neuravi launches EmboTrap in Europe
Neuravi said today it launched its EmboTrap minimally invasive thrombectomy device for the treatment of acute ischemic stroke in Europe. The Embotrap device functions by capturing clots and allowing blood flow to resume immediately after the clot has been secured in patients who have experienced a stroke, CEO Eamon Brady told MassDevice.com in an interview in June. […]
Neuravi raises $21m Series B for thrombectomy device
Neuravi said today that it raised $21 million in a Series B round for its Embotrap minimally invasive thrombectomy device. “The intention of the funding round is to launch the device in Europe, to run the Arise program for the U.S., to attempt to bring the device for U.S. approval and to continue to develop further […]
Neuravi closes $6.5M round for clot retrieval | Funding Roundup
Neuravi successfully completes Series A financing
Irish medical device company Neuravi Limited successfully completed a Series A financing round for $6.5 million (€5.2 million).
